ÌÇÐÄÆƽâ°æ

Share of income utilized in GSK Pharmaceuticals Limited in India in financial year 2025, by category

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2025

Region

India

Survey time period

FY 2025

Supplementary notes

India's fiscal year starts in April and ends in March. For example, FY 2025 started in April 2024 and ended in March 2025.

Citation formats

GSK Pharmaceuticals' share of income utilized in India 2025, by category

Published by A. Minhas, Oct 13, 2025

GlaxoSmithKline Pharmaceuticals Limited in India spent about ** percent of its income in material costs in fiscal year 2025. Further, ** percent of its income was spent on operating expenses, while about **** percent was spent on exchequer contributions. In financial year 2025, GSK ranked as the leading brand in the private vaccine market and dermatology segment.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

GSK (GlaxoSmithKline)SanofiAstraZenecaPharmaceutical industry in the UKVaccine-preventable diseases in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.